Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,604.56
(
0.74%
)
US TECH 100
23,580.40
(
0.95%
)
Dow Jones
46,484.27
(
0.78%
)
Brent Oil
97.68
(
1.22%
)
Bitcoin
70,754.68
(
0.34%
)
News Focus
News Focus

Replies to post #187957 on Biotech Values

Replies to #187957 on Biotech Values
icon url

DewDiligence

02/27/15 2:30 PM

#187958 RE: jbog #187957

Well, that's the bull case for GILD. The bear case is that third-party and government payers don't think TAF-based regimens are worth a large premium price for most HIV patients.